328 related articles for article (PubMed ID: 9593469)
1. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
3. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
5. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic survey of 117 Tunisian patients with de novo myelodysplastic syndrome.
Sendi HS; Hichri H; Elghezal H; Gribaa M; Laatiri A; Elloumi M; Ben Lakhal R; Saad A
Ann Genet; 2002; 45(3):131-5. PubMed ID: 12381443
[TBL] [Abstract][Full Text] [Related]
7. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia.
Bacher U; Haferlach T; Kern W; Haferlach C; Schnittger S
Haematologica; 2007 Jun; 92(6):744-52. PubMed ID: 17550846
[TBL] [Abstract][Full Text] [Related]
9. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.
de Souza Fernandez T; Ornellas MH; Otero de Carvalho L; Tabak D; Abdelhay E
Leuk Res; 2000 Oct; 24(10):839-48. PubMed ID: 10996202
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome abnormalities in myelodysplastic syndrome].
Fujita K; Mori H; Niikura H; Terada H; Shinohara T
Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
17. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
Gmidène A; Sennana H; Fenaux P; Laatiri A; Zarrouk M; Bouaziz H; Harrabi I; Saad A
Leuk Res; 2008 Dec; 32(12):1824-9. PubMed ID: 18556065
[TBL] [Abstract][Full Text] [Related]
19. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.
Lyons J; Janssen JW; Bartram C; Layton M; Mufti GJ
Blood; 1988 Jun; 71(6):1707-12. PubMed ID: 3285909
[TBL] [Abstract][Full Text] [Related]
20. Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes.
Stephenson J; Lizhen H; Mufti GJ
Leuk Res; 1995 Oct; 19(10):741-8. PubMed ID: 7500652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
